Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

NSAID-induced gastrointestinal toxicity

L S Simon1, T Goodman

  • 1Department of Medicine, Harvard Medical School, Boston, MA, USA.

Bulletin on the Rheumatic Diseases
|May 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Directional control of neurite outgrowth: emerging technologies for Parkinson's disease using magnetic nanoparticles and magnetic field gradients.

Journal of the Royal Society, Interface·2022
Same author

Critical appraisal of intra-articular glucocorticoid injections for symptomatic osteoarthritis of the knee.

Osteoarthritis and cartilage·2020
Same author

Corrigendum to Routine exercise-based cardiac rehabilitation does not increase aerobic fitness: A CARE CR study, International Journal of Cardiology, 305 (2020) 25-34.

International journal of cardiology·2020
Same author

Routine exercise-based cardiac rehabilitation does not increase aerobic fitness: A CARE CR study.

International journal of cardiology·2020
Same author

International round-robin experiment for angle-resolved light scattering measurement.

Applied optics·2019
Same author

Optically isolated millimeter-wave detector for the Toroidal Plasma Experiment.

The Review of scientific instruments·2019

To reduce NSAID-induced gastrointestinal events, identify high-risk patients. Use lowest NSAID doses, alternatives, or co-prescribe protective medications like misoprostol for those requiring NSAIDs.

Area of Science:

  • Gastroenterology
  • Pharmacology

Background:

  • Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used but carry risks of gastrointestinal (GI) complications.
  • Identifying patients at high risk for NSAID-induced GI events is crucial for effective management.

Purpose of the Study:

  • To outline strategies for preventing and managing NSAID-induced GI events.
  • To guide clinicians in selecting appropriate treatments for high-risk patients.

Main Methods:

  • Review of current recommendations for NSAID use in at-risk populations.
  • Discussion of prophylactic and therapeutic options including dose reduction, alternative analgesics, misoprostol, H2 antagonists, and omeprazole.
  • Emphasis on endoscopic evaluation for persistent GI bleeding or anemia.

Related Experiment Videos

Main Results:

  • High-risk patients requiring NSAIDs should use the lowest effective dose, non-NSAID alternatives, or nonacetylated salicylates.
  • Concomitant use of misoprostol or other gastroprotective agents (H2 antagonists, omeprazole) is recommended for high-risk patients needing NSAIDs.
  • Prophylactic treatment is generally not advised for low-risk patients unless GI bleeding or anemia develops, necessitating endoscopy and treatment.

Conclusions:

  • Risk stratification is key to preventing NSAID-induced GI harm.
  • A stepwise approach involving dose adjustment, alternative medications, and gastroprotective agents should be employed for high-risk individuals.
  • Prompt diagnosis and management of NSAID-induced ulcers, including H. pylori testing, are essential for patient recovery.